Drugs for Neglected Diseases initiative - DNDi

Over 1 billion people, including 500 million children, in the poorest regions of the world, are affected by neglected diseases that debilitate, disfigure or kill.

12345

SPOTLIGHT

«

»

PILOT POOLED FUND FOR R&D

This recent paper commissioned by DNDi examines the possibilities of creating a pooled international R&D fund for the Demonstration Projects selected as part of the process following on the report of the WHO Consultative Expert Working Group on R&D (CEWG). More

DISEASES & PROJECTS

Neglected tropical diseases continue to cause significant morbidity and mortality in the developing world. Yet, of the 1,556 new drugs approved between 1975 and 2004, only 21 (1.3%) were specifically developed for tropical diseases and tuberculosis, even though these diseases account for 11.4% of the global disease burden.

Human African Trypanosomiasis Endemic in 36 African countries with 60 million people at risk, sleeping sickness or...	Leishmaniasis  Occurring in 98 countries with 350 million people at risk worldwide, leishmaniasis...
Chagas disease Endemic in 21 countries across Latin America and killing more people in the region than malaria...	Malaria Killing one child every 30 seconds in sub-Saharan Africa and approx. 3,000 children every day...
Paediatric HIV 3.3 million children below 15 years of age are living with HIV globally, mainly in sub-Saharan Africa. 700 of them die every day... DNDi’s research and development approach is driven by the real day-to-day needs of patients and healthcare providers.